AGSAVI

DRUG2 trials

Sponsors

Ahn-Gook Pharmaceuticals Co.,Ltd

Conditions

Essential HypertensionHypertension

Phase 3

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Ahn-Gook Pharmaceuticals Co.,LtdHypertension

Start: 2021-02-01End: 2022-05-01Target: 306Updated: 2020-12-29

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

CompletedNCT05503953

Ahn-Gook Pharmaceuticals Co.,LtdEssential Hypertension

Start: 2022-09-13End: 2025-06-10Updated: 2026-09-10